Global Cancer Diagnostics Market Size study, by Diagnostic Type (Diagnostic Imaging, Tests, Biopsy and Cytology Tests, Tumour Biomarkers and Other Diagnostic Types) by Application (Breast Cancer, Lung Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Pancreatic Cancer, Ovarian Cancer and Other Applications) and Regional Forecasts 2022-2028
Global Cancer Diagnostics Market is valued approximately at USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Cancer diagnostics involves identification of different biomarkers, proteins, and some signs that lead to the identification of the presence of a cancerous tumor. Growing prevalence of various types of cancer such as breast, lung, prostate and others are fueling demand for cancer diagnostics globally. According to American Cancer Society, in 2022, about 287,850 new cases of invasive breast cancer will be diagnosed in women and about 43,250 women will die from breast cancer. Also, as per Canadian Cancer Society, 29,600 citizens were diagnosed with lung cancer in 2021 in Canada. Additionally, growing public and private initiatives regarding early diagnosis of cancer and rising number of cancer diagnostic center globally are the factors fueling demand for cancer diagnostic. Furthermore, technological advancements in diagnostic technologies and rising health consciousness among people are expected to fuel growth in the market during forecast period. In November 2021, Siemens Healthineers unveiled Magnetom Free, which is a cost-effective whole-body MRI scanner, designed to enable significantly better access to magnetic resonance imaging globally. However, high cost of cancer diagnostics and lack of proper healthcare infrastructure in developing countries are projected to restrain growth in coming years.
The geographical regions considered for the global Cancer Diagnostics market analysis includes Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is leading the global market in terms of revenue due to continuously growing cancer patients and fast adoption of latest technologies. Whereas, Asia Pacific is expected to grow with the highest growth rate during forecast period due to growing awareness regarding cancer diagnostics and government funding for cancer diagnostic centers.
Major market player included in this report are:
DICKINSON AND COMPANY
F. HOFFMANN-LA ROCHE LTD
THERMO FISHER SCIENTIFIC INC.
ABBOTT LABORATORIES INC.
ILLUMINA INC
BIOMЙRIEUX SA
BIO-RAD LABORATORIES, INC.
ROCHE HOLDINGS AG
DANAHER CORPORATION
HOLOGIC, INC.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Diagnostic Type:
Diagnostic Imaging Tests
Biopsy and Cytology Tests
Tumor Biomarkers
Other Diagnostic Types
By Application:
Breast Cancer
Lung Cancer
Cervical Cancer
Kidney Cancer
Liver Cancer
Pancreatic Cancer
Ovarian Cancer
Other Applications
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Cancer Diagnostics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
The geographical regions considered for the global Cancer Diagnostics market analysis includes Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is leading the global market in terms of revenue due to continuously growing cancer patients and fast adoption of latest technologies. Whereas, Asia Pacific is expected to grow with the highest growth rate during forecast period due to growing awareness regarding cancer diagnostics and government funding for cancer diagnostic centers.
Major market player included in this report are:
DICKINSON AND COMPANY
F. HOFFMANN-LA ROCHE LTD
THERMO FISHER SCIENTIFIC INC.
ABBOTT LABORATORIES INC.
ILLUMINA INC
BIOMЙRIEUX SA
BIO-RAD LABORATORIES, INC.
ROCHE HOLDINGS AG
DANAHER CORPORATION
HOLOGIC, INC.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Diagnostic Type:
Diagnostic Imaging Tests
Biopsy and Cytology Tests
Tumor Biomarkers
Other Diagnostic Types
By Application:
Breast Cancer
Lung Cancer
Cervical Cancer
Kidney Cancer
Liver Cancer
Pancreatic Cancer
Ovarian Cancer
Other Applications
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Cancer Diagnostics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Cancer Diagnostics Market, by region, 2020-2028 (USD Billion)
1.2.2. Cancer Diagnostics Market, by Diagnostic Type, 2020-2028 (USD Billion)
1.2.3. Cancer Diagnostics Market, by Application, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL CANCER DIAGNOSTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL CANCER DIAGNOSTICS MARKET DYNAMICS
3.1. Cancer Diagnostics Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growing prevalence of cancer
3.1.1.2. Growing public and private initiatives regarding early diagnosis of cancer
3.1.2. Market Challenges
3.1.2.1. High cost of cancer diagnosis
3.1.2.2. Lack of proper healthcare infrastructure in developing countries
3.1.3. Market Opportunities
3.1.3.1. Technological advancements
3.1.3.2. Growing health consciousness
CHAPTER 4. GLOBAL CANCER DIAGNOSTICS MARKET: INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
CHAPTER 6. GLOBAL CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE
6.1. Market Snapshot
6.2. Global Cancer Diagnostics Market by Diagnostic Type, Performance - Potential Analysis
6.3. Global Cancer Diagnostics Market Estimates & Forecasts by Diagnostic Type 2019-2028 (USD Billion)
6.4. Cancer Diagnostics Market, Sub Segment Analysis
6.4.1. Diagnostic Imaging Tests
6.4.2. Biopsy and Cytology Tests
6.4.3. Tumour Biomarkers
6.4.4. Other Diagnostic Types
CHAPTER 7. GLOBAL CANCER DIAGNOSTICS MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Cancer Diagnostics Market by Application, Performance - Potential Analysis
7.3. Global Cancer Diagnostics Market Estimates & Forecasts by Application 2019-2028 (USD Billion)
7.4. Cancer Diagnostics Market, Sub Segment Analysis
7.4.1. Breast Cancer
7.4.2. Lung Cancer
7.4.3. Cervical Cancer
7.4.4. Kidney Cancer
7.4.5. Liver Cancer
7.4.6. Pancreatic Cancer
7.4.7. Ovarian Cancer
7.4.8. Other Applications
CHAPTER 8. GLOBAL CANCER DIAGNOSTICS MARKET, REGIONAL ANALYSIS
8.1. Cancer Diagnostics Market, Regional Market Snapshot
8.2. North America Cancer Diagnostics Market
8.2.1. U.S. Cancer Diagnostics Market
8.2.1.1. Diagnostic Type breakdown estimates & forecasts, 2019-2028
8.2.1.2. Application breakdown estimates & forecasts, 2019-2028
8.2.2. Canada Cancer Diagnostics Market
8.3. Europe Cancer Diagnostics Market Snapshot
8.3.1. U.K. Cancer Diagnostics Market
8.3.2. Germany Cancer Diagnostics Market
8.3.3. France Cancer Diagnostics Market
8.3.4. Spain Cancer Diagnostics Market
8.3.5. Italy Cancer Diagnostics Market
8.3.6. Rest of Europe Cancer Diagnostics Market
8.4. Asia-Pacific Cancer Diagnostics Market Snapshot
8.4.1. China Cancer Diagnostics Market
8.4.2. India Cancer Diagnostics Market
8.4.3. Japan Cancer Diagnostics Market
8.4.4. Australia Cancer Diagnostics Market
8.4.5. South Korea Cancer Diagnostics Market
8.4.6. Rest of Asia Pacific Cancer Diagnostics Market
8.5. Latin America Cancer Diagnostics Market Snapshot
8.5.1. Brazil Cancer Diagnostics Market
8.5.2. Mexico Cancer Diagnostics Market
8.6. Rest of The World Cancer Diagnostics Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. DICKINSON AND COMPANY
9.2.1.1. KEY INFORMATION
9.2.1.2. OVERVIEW
9.2.1.3. FINANCIAL (SUBJECT TO DATA AVAILABILITY)
9.2.1.4. PRODUCT SUMMARY
9.2.1.5. RECENT DEVELOPMENTS
9.2.2. F. HOFFMANN-LA ROCHE LTD
9.2.3. THERMO FISHER SCIENTIFIC INC.
9.2.4. ABBOTT LABORATORIES INC.
9.2.5. ILLUMINA INC
9.2.6. BIOMЙRIEUX SA
9.2.7. BIO-RAD LABORATORIES, INC.
9.2.8. ROCHE HOLDINGS AG
9.2.9. DANAHER CORPORATION
9.2.10. HOLOGIC INC.
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Cancer Diagnostics Market, by region, 2020-2028 (USD Billion)
1.2.2. Cancer Diagnostics Market, by Diagnostic Type, 2020-2028 (USD Billion)
1.2.3. Cancer Diagnostics Market, by Application, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL CANCER DIAGNOSTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL CANCER DIAGNOSTICS MARKET DYNAMICS
3.1. Cancer Diagnostics Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growing prevalence of cancer
3.1.1.2. Growing public and private initiatives regarding early diagnosis of cancer
3.1.2. Market Challenges
3.1.2.1. High cost of cancer diagnosis
3.1.2.2. Lack of proper healthcare infrastructure in developing countries
3.1.3. Market Opportunities
3.1.3.1. Technological advancements
3.1.3.2. Growing health consciousness
CHAPTER 4. GLOBAL CANCER DIAGNOSTICS MARKET: INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
CHAPTER 6. GLOBAL CANCER DIAGNOSTICS MARKET, BY DIAGNOSTIC TYPE
6.1. Market Snapshot
6.2. Global Cancer Diagnostics Market by Diagnostic Type, Performance - Potential Analysis
6.3. Global Cancer Diagnostics Market Estimates & Forecasts by Diagnostic Type 2019-2028 (USD Billion)
6.4. Cancer Diagnostics Market, Sub Segment Analysis
6.4.1. Diagnostic Imaging Tests
6.4.2. Biopsy and Cytology Tests
6.4.3. Tumour Biomarkers
6.4.4. Other Diagnostic Types
CHAPTER 7. GLOBAL CANCER DIAGNOSTICS MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Cancer Diagnostics Market by Application, Performance - Potential Analysis
7.3. Global Cancer Diagnostics Market Estimates & Forecasts by Application 2019-2028 (USD Billion)
7.4. Cancer Diagnostics Market, Sub Segment Analysis
7.4.1. Breast Cancer
7.4.2. Lung Cancer
7.4.3. Cervical Cancer
7.4.4. Kidney Cancer
7.4.5. Liver Cancer
7.4.6. Pancreatic Cancer
7.4.7. Ovarian Cancer
7.4.8. Other Applications
CHAPTER 8. GLOBAL CANCER DIAGNOSTICS MARKET, REGIONAL ANALYSIS
8.1. Cancer Diagnostics Market, Regional Market Snapshot
8.2. North America Cancer Diagnostics Market
8.2.1. U.S. Cancer Diagnostics Market
8.2.1.1. Diagnostic Type breakdown estimates & forecasts, 2019-2028
8.2.1.2. Application breakdown estimates & forecasts, 2019-2028
8.2.2. Canada Cancer Diagnostics Market
8.3. Europe Cancer Diagnostics Market Snapshot
8.3.1. U.K. Cancer Diagnostics Market
8.3.2. Germany Cancer Diagnostics Market
8.3.3. France Cancer Diagnostics Market
8.3.4. Spain Cancer Diagnostics Market
8.3.5. Italy Cancer Diagnostics Market
8.3.6. Rest of Europe Cancer Diagnostics Market
8.4. Asia-Pacific Cancer Diagnostics Market Snapshot
8.4.1. China Cancer Diagnostics Market
8.4.2. India Cancer Diagnostics Market
8.4.3. Japan Cancer Diagnostics Market
8.4.4. Australia Cancer Diagnostics Market
8.4.5. South Korea Cancer Diagnostics Market
8.4.6. Rest of Asia Pacific Cancer Diagnostics Market
8.5. Latin America Cancer Diagnostics Market Snapshot
8.5.1. Brazil Cancer Diagnostics Market
8.5.2. Mexico Cancer Diagnostics Market
8.6. Rest of The World Cancer Diagnostics Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. DICKINSON AND COMPANY
9.2.1.1. KEY INFORMATION
9.2.1.2. OVERVIEW
9.2.1.3. FINANCIAL (SUBJECT TO DATA AVAILABILITY)
9.2.1.4. PRODUCT SUMMARY
9.2.1.5. RECENT DEVELOPMENTS
9.2.2. F. HOFFMANN-LA ROCHE LTD
9.2.3. THERMO FISHER SCIENTIFIC INC.
9.2.4. ABBOTT LABORATORIES INC.
9.2.5. ILLUMINA INC
9.2.6. BIOMЙRIEUX SA
9.2.7. BIO-RAD LABORATORIES, INC.
9.2.8. ROCHE HOLDINGS AG
9.2.9. DANAHER CORPORATION
9.2.10. HOLOGIC INC.
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Cancer Diagnostics market, report scope
TABLE 2. Global Cancer Diagnostics market estimates & forecasts by region 2019-2028 (USD Billion)
TABLE 3. Global Cancer Diagnostics market estimates & forecasts by Diagnostic Type 2019-2028 (USD Billion)
TABLE 4. Global Cancer Diagnostics market estimates & forecasts by Application 2019-2028 (USD Billion)
TABLE 5. Global Cancer Diagnostics market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 6. Global Cancer Diagnostics market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 7. Global Cancer Diagnostics market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 8. Global Cancer Diagnostics market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 9. Global Cancer Diagnostics market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 10. Global Cancer Diagnostics market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 11. Global Cancer Diagnostics market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 12. Global Cancer Diagnostics market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 13. Global Cancer Diagnostics market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 14. Global Cancer Diagnostics market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 15. U.S. Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 16. U.S. Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 17. U.S. Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 18. Canada Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 19. Canada Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 20. Canada Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 21. UK Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 22. UK Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 23. UK Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 24. Germany Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 25. Germany Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 26. Germany Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 27. RoE Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 28. RoE Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 29. RoE Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 30. China Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 31. China Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 32. China Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 33. India Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 34. India Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 35. India Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 36. Japan Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 37. Japan Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 38. Japan Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 39. RoAPAC Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 40. RoAPAC Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 41. RoAPAC Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 42. Brazil Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 43. Brazil Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 44. Brazil Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 45. Mexico Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 46. Mexico Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 47. Mexico Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 48. RoLA Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 49. RoLA Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 50. RoLA Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 51. Row Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 52. Row Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 53. Row Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 54. List of secondary sources, used in the study of global Cancer Diagnostics market
TABLE 55. List of primary sources, used in the study of global Cancer Diagnostics market
TABLE 56. Years considered for the study
TABLE 57. Exchange rates considered
TABLE 1. Global Cancer Diagnostics market, report scope
TABLE 2. Global Cancer Diagnostics market estimates & forecasts by region 2019-2028 (USD Billion)
TABLE 3. Global Cancer Diagnostics market estimates & forecasts by Diagnostic Type 2019-2028 (USD Billion)
TABLE 4. Global Cancer Diagnostics market estimates & forecasts by Application 2019-2028 (USD Billion)
TABLE 5. Global Cancer Diagnostics market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 6. Global Cancer Diagnostics market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 7. Global Cancer Diagnostics market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 8. Global Cancer Diagnostics market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 9. Global Cancer Diagnostics market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 10. Global Cancer Diagnostics market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 11. Global Cancer Diagnostics market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 12. Global Cancer Diagnostics market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 13. Global Cancer Diagnostics market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 14. Global Cancer Diagnostics market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 15. U.S. Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 16. U.S. Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 17. U.S. Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 18. Canada Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 19. Canada Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 20. Canada Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 21. UK Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 22. UK Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 23. UK Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 24. Germany Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 25. Germany Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 26. Germany Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 27. RoE Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 28. RoE Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 29. RoE Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 30. China Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 31. China Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 32. China Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 33. India Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 34. India Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 35. India Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 36. Japan Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 37. Japan Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 38. Japan Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 39. RoAPAC Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 40. RoAPAC Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 41. RoAPAC Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 42. Brazil Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 43. Brazil Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 44. Brazil Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 45. Mexico Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 46. Mexico Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 47. Mexico Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 48. RoLA Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 49. RoLA Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 50. RoLA Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 51. Row Cancer Diagnostics market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 52. Row Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 53. Row Cancer Diagnostics market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 54. List of secondary sources, used in the study of global Cancer Diagnostics market
TABLE 55. List of primary sources, used in the study of global Cancer Diagnostics market
TABLE 56. Years considered for the study
TABLE 57. Exchange rates considered
LIST OF FIGURES
FIG 1. Global Cancer Diagnostics market, research methodology
FIG 2. Global Cancer Diagnostics market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Cancer Diagnostics market, key trends 2021
FIG 5. Global Cancer Diagnostics market, growth prospects 2022-2028
FIG 6. Global Cancer Diagnostics market, porters 5 force model
FIG 7. Global Cancer Diagnostics market, pest analysis
FIG 8. Global Cancer Diagnostics market, value chain analysis
FIG 9. Global Cancer Diagnostics market by segment, 2019 & 2028 (USD Billion)
FIG 10. Global Cancer Diagnostics market by segment, 2019 & 2028 (USD Billion)
FIG 11. Global Cancer Diagnostics market by segment, 2019 & 2028 (USD Billion)
FIG 12. Global Cancer Diagnostics market by segment, 2019 & 2028 (USD Billion)
FIG 13. Global Cancer Diagnostics market by segment, 2019 & 2028 (USD Billion)
FIG 14. Global Cancer Diagnostics market, regional snapshot 2019 & 2028
FIG 15. North America Cancer Diagnostics market 2019 & 2028 (USD Billion)
FIG 16. Europe Cancer Diagnostics market 2019 & 2028 (USD Billion)
FIG 17. Asia pacific Cancer Diagnostics market 2019 & 2028 (USD Billion)
FIG 18. Latin America Cancer Diagnostics market 2019 & 2028 (USD Billion)
FIG 19. Global Cancer Diagnostics market, company market share analysis (2021)
FIG 1. Global Cancer Diagnostics market, research methodology
FIG 2. Global Cancer Diagnostics market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Cancer Diagnostics market, key trends 2021
FIG 5. Global Cancer Diagnostics market, growth prospects 2022-2028
FIG 6. Global Cancer Diagnostics market, porters 5 force model
FIG 7. Global Cancer Diagnostics market, pest analysis
FIG 8. Global Cancer Diagnostics market, value chain analysis
FIG 9. Global Cancer Diagnostics market by segment, 2019 & 2028 (USD Billion)
FIG 10. Global Cancer Diagnostics market by segment, 2019 & 2028 (USD Billion)
FIG 11. Global Cancer Diagnostics market by segment, 2019 & 2028 (USD Billion)
FIG 12. Global Cancer Diagnostics market by segment, 2019 & 2028 (USD Billion)
FIG 13. Global Cancer Diagnostics market by segment, 2019 & 2028 (USD Billion)
FIG 14. Global Cancer Diagnostics market, regional snapshot 2019 & 2028
FIG 15. North America Cancer Diagnostics market 2019 & 2028 (USD Billion)
FIG 16. Europe Cancer Diagnostics market 2019 & 2028 (USD Billion)
FIG 17. Asia pacific Cancer Diagnostics market 2019 & 2028 (USD Billion)
FIG 18. Latin America Cancer Diagnostics market 2019 & 2028 (USD Billion)
FIG 19. Global Cancer Diagnostics market, company market share analysis (2021)
